Praedicat Joins Moody’s: A New Era of Innovation in Casualty Risk Assessment We are excited to announce that Praedicat has officially joined the Moody’s family, marking a significant milestone in…
read moreFilter posts by:
Praedicat is joining Moody’s I have very big news. Today, Praedicat has been acquired by Moody’s and I couldn’t be more delighted. Joining the Moody’s family represents the culmination of…
read moreUnderstanding the Growing Wave of Mass Torts: Are We Prepared for What’s Ahead? The hair relaxer litigation that began in October 2022 marks just the tip of a much…
read morePraedicat Shortlisted for “Risk Modeler of the Year” by Insurance Insider We are delighted to share the exciting news that Praedicat has been named as one of two finalists for…
read moreManaging PFAS Exposure, with Julia Fuller-Nakayama Litigation over PFAS, the forever chemical, continued its march toward assuming the mantle of the next asbestos in 2024. Some are responding with…
read moreAt Praedicat, we firmly believe that within every challenge lies an opportunity. Our experience has shown that with the right data, analytics and insights, you can embrace emerging risks and…
read moreThe Long & Winding Road to Diesel Emissions Litigation Anybody who watched a truck accelerate in the 1990s likely remembers the thick clouds of black diesel exhaust billowing out of…
read moreWith the recent release of Praedicat’s securities class action litigation tracking module in CoMeta, Praedicat now offers an integrated D&O underwriting and portfolio management solution that brings together baseline D&O…
read more2B or Not 2B? That Was the Question for Aspartame In our recent Carrier Management article, titled “2B or Not 2B? That Was the Question for Aspartame,” we delve into…
read moreAon panel debate: Casualty capacity still available as renewal dynamics shift | The Insurer TV Praedicat CEO Robert Reville had the pleasure of joining Aon’s panel debate on The…
read morePraedicat’s top emerging risk? PFAS, and with good reason. Praedicat has recently completed an analysis of potential chemical liabilities in support of the release of the 2023 edition of ChemScore.…
read moreOur own David Loughran and Graham Tibbets join Matthew B. Anderson, Travis Grulkowski and Drew Goth to co-author the newest report from Milliman, The “forever chemical” risk is now: An…
read more